FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126042521> ?p ?o ?g. }

• W2126042521 endingPage "5367" @default.
• W2126042521 startingPage "5360" @default.
• W2126042521 abstract "Imatinib mesylate is standard treatment for patients who have advanced gastrointestinal stromal tumor (GIST), but not all patients benefit equally. In previous studies, GIST genotype correlated with treatment outcome and optimal imatinib dosing.We examined the relationship between kinase genotype and treatment outcome for 428 patients enrolled on the North American phase III study SWOG S0033/CALGB 150105 and treated with either 400 mg or 800 mg daily doses of imatinib.The presence of KIT exon 11-mutant genotype (n = 283) correlated with improved treatment outcome when compared with KIT exon 9-mutant (n = 32) and wild-type (WT; n = 67) genotypes for objective response (complete response [CR]/partial response [PR], 71.7% v 44.4% [P = .007]; and 44.6% [P = .0002], respectively); time to tumor progression (TTP; median 24.7 months v 16.7 and 12.8 months, respectively); and overall survival (OS; median 60.0 months v 38.4 and 49.0 months, respectively). The survival outcomes for patients with exon 9-mutant, exon 11-mutant or WT GIST were not affected by imatinib dose. However, there was evidence of improved response rates for patients with exon 9-mutant tumors treated with imatinib 800 mg versus 400 mg (CR/PR, 67% v 17%; P = .02). Patients who had CD117-negative GIST had similar TTP but inferior OS compared with patients who had CD117-positive disease, which suggests that patients who have CD117-negative GIST may benefit from imatinib treatment. In addition, we identified novel but rare mutations of the KIT extracellular domain (exons 8 and 9).We confirmed the favorable impact of KIT exon 11 genotype when compared with KIT exon 9 and wild-type genotype for patients with advanced GIST who are treated with imatinib." @default.
• W2126042521 created "2016-06-24" @default.
• W2126042521 creator A5000206324 @default.
• W2126042521 creator A5008289953 @default.
• W2126042521 creator A5017709484 @default.
• W2126042521 creator A5026593581 @default.
• W2126042521 creator A5031078301 @default.
• W2126042521 creator A5037149615 @default.
• W2126042521 creator A5040359760 @default.
• W2126042521 creator A5042631007 @default.
• W2126042521 creator A5046099119 @default.
• W2126042521 creator A5050651568 @default.
• W2126042521 creator A5056562780 @default.
• W2126042521 creator A5060580923 @default.
• W2126042521 creator A5068869646 @default.
• W2126042521 creator A5085336500 @default.
• W2126042521 creator A5091057405 @default.
• W2126042521 date "2008-11-20" @default.
• W2126042521 modified "2023-10-14" @default.
• W2126042521 title "Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group" @default.
• W2126042521 cites W1933891757 @default.
• W2126042521 cites W1975240950 @default.
• W2126042521 cites W1983235255 @default.
• W2126042521 cites W1993602900 @default.
• W2126042521 cites W1995930366 @default.
• W2126042521 cites W2000998080 @default.
• W2126042521 cites W2015015957 @default.
• W2126042521 cites W2032771230 @default.
• W2126042521 cites W2068079378 @default.
• W2126042521 cites W2074608272 @default.
• W2126042521 cites W2077976050 @default.
• W2126042521 cites W2079420659 @default.
• W2126042521 cites W2101214437 @default.
• W2126042521 cites W2101986793 @default.
• W2126042521 cites W2102769930 @default.
• W2126042521 cites W2115504770 @default.
• W2126042521 cites W2119238883 @default.
• W2126042521 cites W2129931005 @default.
• W2126042521 cites W2134094496 @default.
• W2126042521 cites W2137791754 @default.
• W2126042521 cites W2138647235 @default.
• W2126042521 cites W2140626630 @default.
• W2126042521 cites W2145131634 @default.
• W2126042521 cites W2150501295 @default.
• W2126042521 cites W2157686263 @default.
• W2126042521 cites W2169363650 @default.
• W2126042521 cites W2171620774 @default.
• W2126042521 cites W2324850882 @default.
• W2126042521 doi "https://doi.org/10.1200/jco.2008.17.4284" @default.
• W2126042521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2651078" @default.
• W2126042521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18955451" @default.
• W2126042521 hasPublicationYear "2008" @default.
• W2126042521 type Work @default.
• W2126042521 sameAs 2126042521 @default.
• W2126042521 citedByCount "535" @default.
• W2126042521 countsByYear W21260425212012 @default.
• W2126042521 countsByYear W21260425212013 @default.
• W2126042521 countsByYear W21260425212014 @default.
• W2126042521 countsByYear W21260425212015 @default.
• W2126042521 countsByYear W21260425212016 @default.
• W2126042521 countsByYear W21260425212017 @default.
• W2126042521 countsByYear W21260425212018 @default.
• W2126042521 countsByYear W21260425212019 @default.
• W2126042521 countsByYear W21260425212020 @default.
• W2126042521 countsByYear W21260425212021 @default.
• W2126042521 countsByYear W21260425212022 @default.
• W2126042521 countsByYear W21260425212023 @default.
• W2126042521 crossrefType "journal-article" @default.
• W2126042521 hasAuthorship W2126042521A5000206324 @default.
• W2126042521 hasAuthorship W2126042521A5008289953 @default.
• W2126042521 hasAuthorship W2126042521A5017709484 @default.
• W2126042521 hasAuthorship W2126042521A5026593581 @default.
• W2126042521 hasAuthorship W2126042521A5031078301 @default.
• W2126042521 hasAuthorship W2126042521A5037149615 @default.
• W2126042521 hasAuthorship W2126042521A5040359760 @default.
• W2126042521 hasAuthorship W2126042521A5042631007 @default.
• W2126042521 hasAuthorship W2126042521A5046099119 @default.
• W2126042521 hasAuthorship W2126042521A5050651568 @default.
• W2126042521 hasAuthorship W2126042521A5056562780 @default.
• W2126042521 hasAuthorship W2126042521A5060580923 @default.
• W2126042521 hasAuthorship W2126042521A5068869646 @default.
• W2126042521 hasAuthorship W2126042521A5085336500 @default.
• W2126042521 hasAuthorship W2126042521A5091057405 @default.
• W2126042521 hasBestOaLocation W21260425211 @default.
• W2126042521 hasConcept C10205521 @default.
• W2126042521 hasConcept C104317684 @default.
• W2126042521 hasConcept C126322002 @default.
• W2126042521 hasConcept C135763542 @default.
• W2126042521 hasConcept C143998085 @default.
• W2126042521 hasConcept C16930146 @default.
• W2126042521 hasConcept C2775922572 @default.
• W2126042521 hasConcept C2776839831 @default.
• W2126042521 hasConcept C2777007597 @default.
• W2126042521 hasConcept C2777583451 @default.
• W2126042521 hasConcept C2778729363 @default.
• W2126042521 hasConcept C28328180 @default.
• W2126042521 hasConcept C3019892230 @default.
• W2126042521 hasConcept C36823959 @default.

• next